Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid Arthritis Patients
1/7/2009 8:27:43 AM
More...
|
Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
7/21/2008 11:09:46 AM
More...
|
Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
5/12/2008 10:49:35 AM
More...
|
President and CEO of Velcura Therapeutics, Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
5/9/2008 7:10:49 AM
More...
|
Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants
2/4/2008 7:47:44 AM
More...
|
Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
1/28/2008 10:07:22 AM
More...
|
Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs
10/15/2007 10:34:27 AM
More...
|
Former Pfizer Inc. (PFE) Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics, Inc. Inflammatory Disease Initiatives
10/4/2007 8:28:43 AM
More...
|
NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D Dual-Action Therapies for Bone Disease
9/28/2007 7:40:24 AM
More...
|
Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
9/24/2007 7:50:37 AM
More...
|
|